These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8595997)

  • 1. Stroke prevention: the emerging strategies.
    McCrory DC; Matchar DB
    Hosp Pract (1995); 1996 Mar; 31(3):123-8,131-2,134. PubMed ID: 8595997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials.
    Albers GW; Sherman DG; Gress DR; Paulseth JE; Petersen P
    Ann Neurol; 1991 Oct; 30(4):511-8. PubMed ID: 1789680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and stroke. Three new studies, three remaining questions.
    Albers GW
    Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of thromboembolic events in atrial fibrillation.
    Koefoed BG; Gulløv AL; Petersen P
    Thromb Haemost; 1997 Jul; 78(1):377-81. PubMed ID: 9198182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
    Hu DY; Zhang HP; Sun YH; Jiang LQ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
    Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
    CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [European atrial fibrillation trial (EAFT). Secondary prevention with anticoagulants and aspirin in patients with non-valvular atrial fibrillation having suffered a transient ischemic attack or a regressive vascular accident].
    Besson G; Bogousslavsky J
    Rev Med Suisse Romande; 1991 Jan; 111(1):49-55. PubMed ID: 2006364
    [No Abstract]   [Full Text] [Related]  

  • 10. Stroke prevention in non-rheumatic atrial fibrillation.
    Duncan GW
    Tenn Med; 1997 Jan; 90(1):21-2. PubMed ID: 8997157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
    Kutner M; Nixon G; Silverstone F
    Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.
    Stratton JR
    West J Med; 1995 Aug; 163(2):177-9. PubMed ID: 7571577
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke prevention in atrial fibrillation.
    Halperin JL; Rothlauf EB
    Mt Sinai J Med; 1993 Sep; 60(4):289-94. PubMed ID: 8232372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of stroke.
    Martinez-Riera A; Santolaria-Fernandez F; Gonzalez-Reimers E
    N Engl J Med; 1996 Apr; 334(17):1138; author reply 1139. PubMed ID: 8598884
    [No Abstract]   [Full Text] [Related]  

  • 16. Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.
    Morrison CM; Gainsborough N; Rajkumar C
    Age Ageing; 2007 Mar; 36(2):117-9. PubMed ID: 17255089
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulation: risks and benefits in atrial fibrillation.
    Fiore LD
    Geriatrics; 1996 Jun; 51(6):22-4, 27-8, 31. PubMed ID: 8647473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation, thromboembolism and antithrombotic therapy.
    Li-Saw-Hee FL; Lip GY
    Int J Clin Pract; 1999 Mar; 53(2):110-7. PubMed ID: 10344046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arkansas Foundation for Medical Care report: preventing stroke in atrial fibrillation.
    Golden WE; Cleves M
    J Ark Med Soc; 1994 Feb; 90(9):439-40. PubMed ID: 8163427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A; Downes T; Portner R; Yeo WW; Morgan N; Channer KS
    Age Ageing; 2007 Mar; 36(2):151-6. PubMed ID: 17175564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.